A detailed history of Patton Fund Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Patton Fund Management, Inc. holds 11,430 shares of AMGN stock, worth $3.19 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
11,430
Previous 12,049 5.14%
Holding current value
$3.19 Million
Previous $3.76 Million 2.18%
% of portfolio
0.77%
Previous 0.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$309.38 - $337.38 $191,506 - $208,838
-619 Reduced 5.14%
11,430 $3.68 Million
Q2 2024

Jul 16, 2024

SELL
$262.75 - $319.31 $665,283 - $808,492
-2,532 Reduced 17.37%
12,049 $3.76 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $3.92 Million - $4.73 Million
14,581 New
14,581 $4.15 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $2.34 Million - $2.97 Million
10,203 New
10,203 $2.68 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Patton Fund Management, Inc. Portfolio

Follow Patton Fund Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patton Fund Management, Inc. with notifications on news.